Silicon-rich silicon oxide thin films have been prepared by thermal evaporation of silicon monoxide in vacuum. The SiOx film composition (1.1⩽ x ⩽1.7) has been controlled by varying the deposition rate and residual pressure in the chamber. Long time stability of all films has been ensured by a postdeposition annealing at 523 K for 30 min in Ar atmosphere. Some films were further annealed at 973 K and some others at 1303 K. Raman scattering measurements have implied the formation of amorphous silicon nanoparticles in films annealed at 973 K and Si nanocrystals in films annealed at 1303 K. The latter conclusion is strongly supported by high resolution electron microscopy studies which show a high density of Si nanocrystals in these films. Photoluminescence has been observed from both amorphous and crystalline nanoparticles and interpreted in terms of band-to-band recombination in the nanoparticles having average size greater than 2.5 nm and carrier recombination through defect states in smaller nanoparticles.
The high-pressure Raman spectra of ZnF 2 have been measured up to 6.8 GPa and provided unambiguous evidence of a phase transition from its ambient-pressure rutile ͑D 4h 14 ͒ to the CaCl 2 -type orthorhombic ͑D 2h 12 ͒ structure at a pressure P c Ϸ 4.5 GPa. Both macro-and micro-Raman spectra have been independently obtained at high pressures leading to the same conclusion about the high-pressure phase and the P c . The transition appears to be closely associated with the B 1g ͑A g ͒ Raman-active soft mode of the rutile ͑CaCl 2 ͒ structure, implying that ZnF 2 undergoes a second-order ferroelastic phase transition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.